6 completed, 1 unknown. 3 Not applicable, 2 Phase 2, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 3 |
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Insulin-dependent Diabetes Mellitus: new trials by email Literature Review of Insulin-dependent Diabetes Mellitus trials Research Report on Insulin-dependent Diabetes Mellitus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DreaMed Advisor Pro System in Subjects With Type 1 Diabetes Treated With MDI Therapy Advisor Pro - Insulin-dependent Diabetes Mellitus, Diabetes Mellitus, Type 1 | Not applicable | Completed | DreaMed Diabetes | 35 | 2019-11-27 | 2021-08-17 |
| Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D PRAM9, Regular Insulin + Pramlintide, Regular Insulin - Diabetes Mellitus, Type 1, Insulin-dependent Diabetes Mellitus | Phase 2 | Completed | Xeris Pharmaceuticals | 18 | 2019-08-22 | 2024-03-27 |
| Information and Communication Technology Based Centralized Clinical Trial Monitoring System for Insulin Dose Adjustment Algorithm-based feedback messages, Personal Health Record - Diabetes Mellitus, Insulin Hypoglycemia | Not applicable | Completed | Samsung Medical Center | 112 | 2017-09-26 | 2019-04-05 |
| Switching From Insulin to Sulfonylurea in Diabetes Associated With Variants in MODY Genes Sulfonylurea - Maturity-Onset Diabetes of the Young, Type 3, Maturity Onset Diabetes of the Young, Type 1 | Phase 4 | Unknown | Haukeland University Hospital | 30 | 2017-04-18 | 2020-01-27 |
| Evaluation of a Diabetes Vaccine in Newly Diagnosed Diabetics IBC-VS01, IBC-VS01 placebo - Insulin-dependent Diabetes Mellitus, Diabetes Mellitus | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 12 | 2003-03-01 | 2017-02-08 |
| Interferon-Alpha for Diabetes Mellitus Type 1 30,000 units hrINF-alpha, 5,000 hrINF-alpha, Placebo - Insulin-Dependent Diabetes Mellitus | Phase 2 | Completed | The University of Texas Health Science Center, Houston | 57 | 2001-09-01 | 2013-11-19 |
| African-American Diabetes Intervention Project home based worker - Insulin-Dependent Diabetes Mellitus | Not applicable | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2010-02-15 |
Diabetes Mellitus, Type 1 (7) · Diabetes Mellitus (3) · Insulin Resistance (1) · Maturity-Onset Diabetes of the Young, Type 1 (1) · Maturity-Onset Diabetes of the Young, Type 3 (1)
Autoimmune Diseases (7) · Endocrine System Diseases (7) · Glucose Metabolism Disorders (7) · Immune System Diseases (7) · Metabolic Diseases (7) · Nutritional and Metabolic Diseases (7) · Diabetes Mellitus (4) · Hyperinsulinism (1)
Glipizide (1) · Glyburide (1) · Health Records, Personal (1) · Insulin (1) · Sulfonylurea Compounds (1) · pramlintide (1)
DreaMed Diabetes (1) · Haukeland University Hospital (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Samsung Medical Center (1) · The University of Texas Health Science Center, Houston (1) · Xeris Pharmaceuticals (1)
United States (4) · Israel (1) · Norway (1) · South Korea (1)
Andrea Valasquez (1) · George Atiee (1) · Kristina I Rother, M.D. (1) · Sang-Man Jin, MD PhD (1) · Staley A Brod, MD (1) · Tihamer Orban, MD (1) · Yael Shtrit (1)